Pages that link to "Q81723852"

The following pages link to Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II (Q81723852):

Displaying 14 items.

• Nanomechanics and sodium permeability of endothelial surface layer modulated by hawthorn extract WS 1442. (Q34130862) (← links)
• Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research (Q34667430) (← links)
• Sugar-coating wound repair: a review of FGF-10 and dermatan sulfate in wound healing and their potential application in burn wounds (Q38637477) (← links)
• Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice (Q36447954) (← links)
• Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II (Q36528769) (← links)
• The biosynthesis and catabolism of galactosaminoglycans (Q36713824) (← links)
• The endothelial glycocalyx: composition, functions, and visualization (Q36719459) (← links)
• Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study (Q37438938) (← links)
• Vascular Dermatan Sulfate and Heparin Cofactor II (Q37784316) (← links)
• Approaches to prevent bleeding associated with anticoagulants: current status and recent developments (Q39456319) (← links)
• Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas. (Q39861917) (← links)
• Alterations of fibrin network structure mediated by dermatan sulfate (Q45231010) (← links)
• Structure and elasticity of bush and brush-like models of the endothelial glycocalyx (Q48267335) (← links)
• The dermatan sulfate-dependent anticoagulant pathway is mostly preserved in aneurysm and in severe atherosclerotic lesions while the heparan sulfate pathway is disrupted (Q52607171) (← links)